当前位置： SCI文献检索 > BMC CANCER期刊下所有文献 > High BANCR expression is associated with worse prognosis in human malignant carcinomas: an updated systematic review and meta-analysis.

High BANCR expression is associated with worse prognosis in human malignant carcinomas: an updated systematic review and meta-analysis.

Abstract：

BACKGROUND:BRAF-activated noncoding RNA (BANCR) is aberrantly expressed in various tumor tissues and has been confirmed to function as a tumor suppressor or oncogene in many types of cancers. Considering the conflicting results and insufficient sampling, a meta-analysis was performed to explore the prognostic value of BANCR in various carcinomas. METHODS:A comprehensive literature search of PubMed, Web of Science, EMBASE, Cochrane Library and the China National Knowledge Infrastructure (CNKI) was conducted to collect relevant articles. RESULTS:The pooled results showed a strong relationship between high BANCR expression and poor overall survival (OS) (HR (hazard ratio) =1.60, 95% confidence interval (CI): 1.19-2.15, P = 0.002) and recurrence-free survival (RFS) (HR = 1.53, 95% CI: 1.27-1.85, P < 0.00001). In addition, high BANCR expression predicted advanced tumor stage (OR (odds ratio) =2.39, 95% CI: 1.26-4.53, P = 0.008), presence of lymph node metastasis (OR = 2.03, 95% CI: 1.08-3.83, P = 0.03), positive distant metastasis (OR = 3.08, 95% CI: 1.92-4.96, P < 0.00001) and larger tumor sizes (OR = 1.63, 95% CI: 1.09-2.46, P = 0.02). However, no associations were found for smoking status (OR = 1.01, 95% CI: 0.65-1.56, P = 0.98), age (OR = 0.88, 95% CI: 0.71-1.09, P = 0.236) and sex (OR = 0.91, 95% CI: 0.72-1.16, P = 0.469). The sensitivity analysis of OS showed that the results of each publication were almost consistent with the combined results, and the merged results have high robustness and reliability. CONCLUSIONS:The results showed that elevated BANCR expression was associated with unfavorable prognosis for most cancer patients, and BANCR could serve as a promising therapeutic target and independent prognostic predictor in most of cancer types.

journal_name

BMC Cancer

journal_title

BMC cancer

authors

Fang S,Liu Z,Guo Q,Chen C,Ke X,Xu G

doi

10.1186/s12885-020-07177-6

subject

Has Abstract

pub_date

2020-09-09 00:00:00

pages

870

issue

1

issn

1471-2407

pii

10.1186/s12885-020-07177-6

journal_volume

20

pub_type

杂志文章

相关文献

BMC CANCER文献大全
  • The NF-κB p65 and p50 homodimer cooperate with IRF8 to activate iNOS transcription.

    abstract：BACKGROUND:Inducible nitric oxide synthase (iNOS) metabolizes L-arginine to produce nitric oxide (NO) which was originally identified in myeloid cells as a host defense mechanism against pathogens. Recent studies, however, have revealed that iNOS is often induced in tumor cells and myeloid cells in the tumor microenvir...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-015-1808-6

    authors： Simon PS,Sharman SK,Lu C,Yang D,Paschall AV,Tulachan SS,Liu K

    更新日期：2015-10-23 00:00:00

  • Risk of uterine, ovarian and breast cancer following pelvic inflammatory disease: a nationwide population-based retrospective cohort study.

    abstract：BACKGROUND:Pelvic inflammatory disease (PID) is characterized by infection and inflammation of the upper genital tract in women and is associated with health sequelae. We used a nationwide population-based retrospective cohort study to explore the relationship between PID and the subsequent development of gynecological...

    journal_title：BMC cancer

    pub_type： 杂志文章,随机对照试验

    doi：10.1186/s12885-016-2857-1

    authors： Shen CC,Hu LY,Yang AC,Chiang YY,Hung JH,Tsai SJ

    更新日期：2016-11-03 00:00:00

  • Low expression of c-Myc protein predicts poor outcomes in patients with hepatocellular carcinoma after resection.

    abstract：BACKGROUND:Embryonic Liver Fodrin (ELF) is an adaptor protein of transforming growth factor (TGF-β) signaling cascade. Disruption of ELF results in mislocalization of Smad3 and Smad4, leading to compromised TGF-β signaling. c-Myc is an important oncogenic transcription factor, and the disruption of TGF-β signaling prom...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-018-4379-5

    authors： Ji F,Zhang ZH,Zhang Y,Shen SL,Cao QH,Zhang LJ,Li SQ,Peng BG,Liang LJ,Hua YP

    更新日期：2018-04-24 00:00:00

  • Disclosure in lesbian, gay and bisexual cancer care: towards a salutogenic healthcare environment.

    abstract：BACKGROUND:The literature on sexual orientation disclosure is arguably one of the most developed in the field of lesbian, gay and bisexual (LGB) people in healthcare in English speaking countries however, relatively little research has been conducted into disclosure in cancer care. Studies have been mainly undertaken i...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-019-5895-7

    authors： Fish J,Williamson I,Brown J

    更新日期：2019-07-10 00:00:00

  • Using Resistin, glucose, age and BMI to predict the presence of breast cancer.

    abstract：BACKGROUND:The goal of this exploratory study was to develop and assess a prediction model which can potentially be used as a biomarker of breast cancer, based on anthropometric data and parameters which can be gathered in routine blood analysis. METHODS:For each of the 166 participants several clinical features were ...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-017-3877-1

    authors： Patrício M,Pereira J,Crisóstomo J,Matafome P,Gomes M,Seiça R,Caramelo F

    更新日期：2018-01-04 00:00:00

  • UDP-glucuronosyltransferases and biochemical recurrence in prostate cancer progression.

    abstract：BACKGROUND:Uridine 5'-diphosphate-glucuronosyltransferase 2B (UGT2B) genes code for enzymes that catalyze the clearance of testosterone, dihydrotestosterone (DHT), and DHT metabolites in the prostate basal and luminal tissue. The expression of the UGT2B15, UGT2B17, and UGT2B28 enzymes has not been evaluated in prostate...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-017-3463-6

    authors： Grant DJ,Chen Z,Howard LE,Wiggins E,De Hoedt A,Vidal AC,Carney ST,Squires J,Magyar CE,Huang J,Freedland SJ

    更新日期：2017-07-03 00:00:00

  • Nodal induces apoptosis and inhibits proliferation in ovarian endometriosis-clear cell carcinoma lesions.

    abstract：BACKGROUND:Expression of Nodal, a member of the TGF-β superfamily, is commonly absent in differentiated tissues, while its re-expression occurs in a variety of human malignancy. However, little is known about its involvement in ovarian tumorigenesis. Herein, we focused on the functional roles of Nodal in ovarian endome...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-019-5539-y

    authors： Miura R,Yokoi A,Matsumoto T,Oguri Y,Hashimura M,Tochimoto M,Kajita S,Saegusa M

    更新日期：2019-04-03 00:00:00

  • Patterns of follow up and survivorship care for people with colorectal cancer in new South Wales, Australia: a population-based survey.

    abstract：BACKGROUND:The incidence and survival rates for colorectal cancer in Australia are among the highest in the world. With population growth and ageing there are increasing numbers of colorectal cancer survivors in the community, yet little is known of their ongoing follow up and survivorship care experiences. This study ...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-018-4297-6

    authors： Young JM,Durcinoska I,DeLoyde K,Solomon MJ

    更新日期：2018-03-27 00:00:00

  • The lack of clinical value of peritoneal washing cytology in high risk patients undergoing risk-reducing salpingo-oophorectomy: a retrospective study and review.

    abstract：BACKGROUND:To assess the clinical value of peritoneal washing cytology (PWC) in women with BRCA1 or BRCA2 mutations and women from a family with hereditary breast and/or ovarian cancer (HBOC) undergoing risk-reducing salpingo-oophorectomy (RRSO) in detecting primary peritoneal cancer (PPC) or occult ovarian/fallopian t...

    journal_title：BMC cancer

    pub_type： 杂志文章,meta分析,评审

    doi：10.1186/s12885-015-2011-5

    authors： Blok F,Roes EM,van Leenders GJ,van Beekhuizen HJ

    更新日期：2016-01-14 00:00:00

  • A high-throughput and sensitive method to measure global DNA methylation: application in lung cancer.

    abstract：BACKGROUND:Genome-wide changes in DNA methylation are an epigenetic phenomenon that can lead to the development of disease. The study of global DNA methylation utilizes technology that requires both expensive equipment and highly specialized skill sets. METHODS:We have designed and developed an assay, CpGlobal, which ...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/1471-2407-8-222

    authors： Anisowicz A,Huang H,Braunschweiger KI,Liu Z,Giese H,Wang H,Mamaev S,Olejnik J,Massion PP,Del Mastro RG

    更新日期：2008-08-03 00:00:00

  • Flemish breast cancer screening programme: 15 years of key performance indicators (2002-2016).

    abstract：BACKGROUND:We examined 15 years of key performance indicators (KPIs) of the population-based mammography screening programme (PMSP) in Flanders, Belgium. METHODS:Individual screening data were linked to the national cancer registry to obtain oncological follow-up. We benchmarked crude KPI results against KPI-targets s...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-019-6230-z

    authors： Goossens M,De Brabander I,De Grève J,Van Ongeval C,Martens P,Van Limbergen E,Kellen E

    更新日期：2019-10-28 00:00:00

  • Underutilization and disparities in access to EGFR testing among Medicare patients with lung cancer from 2010 - 2013.

    abstract：BACKGROUND:Tumor testing for mutations in the epidermal growth factor receptor (EGFR) gene is indicated for all newly diagnosed, metastatic lung cancer patients, who may be candidates for first-line treatment with an EGFR tyrosine kinase inhibitor. Few studies have analyzed population-level testing. METHODS:We identif...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-018-4190-3

    authors： Lynch JA,Berse B,Rabb M,Mosquin P,Chew R,West SL,Coomer N,Becker D,Kautter J

    更新日期：2018-03-20 00:00:00

  • A retrospective analysis of survival and prognostic factors of male breast cancer from a single center.

    abstract：BACKGROUND:Less than 1% of all breast cancer cases are found in men, who reportedly have inferior outcomes compared with matched women patients. Ethnic differences may also affect their prognosis. Here, we investigated overall survival (OS) and major prognostic factors for male breast cancer (MBC) in a cohort of Egypti...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/1471-2407-14-227

    authors： Soliman AA,Denewer AT,El-Sadda W,Abdel-Aty AH,Refky B

    更新日期：2014-03-28 00:00:00

  • Low-cost HPV testing and the prevalence of cervical infection in asymptomatic populations in Guatemala.

    abstract：BACKGROUND:A low cost and accurate method for detecting high-risk (HR) human papillomavirus (HPV) is important to permit HPV testing for cervical cancer prevention. We used a commercially available HPV method (H13, Hybribio) which was documented to function accurately in a reduced volume of cervical specimen to determi...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-018-4438-y

    authors： Lou H,Gharzouzi E,Guerra SP,Fokom Domgue J,Sawitzke J,Villagran G,Garland L,Boland JF,Wagner S,Rosas H,Troxler J,McMillen H,Kessing B,Alvirez E,Castillo M,Morales H,Argueta V,Rosingh A,van Aerde-van Nunen FJHB,Lopez

    更新日期：2018-05-15 00:00:00

  • CD31 and VEGF are prognostic biomarkers in early-stage, but not in late-stage, laryngeal squamous cell carcinoma.

    abstract：BACKGROUND:Patients suffering from squamous cell carcinoma of the larynx (LSCC) with lymphatic metastasis have a relatively poor prognosis and often require radical therapeutic management. The mechanisms which drive metastasis to the lymph nodes are largely unknown but may be promoted by a pro-angiogenic tumor microenv...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-018-4180-5

    authors： Schlüter A,Weller P,Kanaan O,Nel I,Heusgen L,Höing B,Haßkamp P,Zander S,Mandapathil M,Dominas N,Arnolds J,Stuck BA,Lang S,Bankfalvi A,Brandau S

    更新日期：2018-03-09 00:00:00

  • High-precision radiotherapy of motor deficits due to metastatic spinal cord compression (PRE-MODE): a multicenter phase 2 study.

    abstract：BACKGROUND:For metastatic spinal cord compression (MSCC), conventional radiotherapy with 10 × 3 Gy in 2 weeks results in better local progression-free survival (LPFS) than 5 × 4 Gy in 1 week. Since patients with MSCC are often significantly impaired, an overall treatment time of 1 week would be preferable if resulting ...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-017-3844-x

    authors： Rades D,Cacicedo J,Conde-Moreno AJ,Doemer C,Dunst J,Lomidze D,Segedin B,Olbrich D,Holländer NH

    更新日期：2017-12-04 00:00:00

  • Circular RNA hsa_circ_0000282 contributes to osteosarcoma cell proliferation by regulating miR-192/XIAP axis.

    abstract：BACKGROUND:Circular RNAs (circRNAs) have emerged as a novel category of non-coding RNA, which exhibit a pivotal effect on regulating gene expression and biological functions, yet how circRNAs function in osteosarcoma (OSA) still demands further investigation. This study aimed at probing into the function of hsa_circ_00...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-020-07515-8

    authors： Li H,He L,Tuo Y,Huang Y,Qian B

    更新日期：2020-10-23 00:00:00

  • Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ.

    abstract：BACKGROUND:Invasion is often found during postoperative pathological examination of cases diagnosed as ductal carcinoma in situ (DCIS) by histological examinations such as core needle biopsy (CNB) or vacuum-assisted biopsy (VAB). A meta-analysis reported that 25.9% of invasive ductal carcinoma (IDC) cases are preoperat...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-020-07001-1

    authors： Takada K,Kashiwagi S,Asano Y,Goto W,Morisaki T,Takahashi K,Fujita H,Takashima T,Tomita S,Hirakawa K,Ohira M

    更新日期：2020-06-03 00:00:00

  • The 2018 Nobel Prize in medicine goes to cancer immunotherapy (editorial for BMC cancer).

    abstract：: ...

    journal_title：BMC cancer

    pub_type： 社论,历史文章

    doi：10.1186/s12885-018-5020-3

    authors： Guo ZS

    更新日期：2018-11-12 00:00:00

  • Prognostic significance of p53 expression in patients with esophageal cancer: a meta-analysis.

    abstract：BACKGROUND:The prognostic value of p53 protein expression in esophageal cancer has been evaluated, but the results remain inconclusive and no consensus has yet been achieved. This meta-analysis was conducted to quantitatively assess the prognostic significance of p53 expression in esophageal cancer. METHODS:Publicatio...

    journal_title：BMC cancer

    pub_type： 杂志文章,meta分析

    doi：10.1186/s12885-016-2427-6

    authors： Wang L,Yu X,Li J,Zhang Z,Hou J,Li F

    更新日期：2016-07-01 00:00:00

  • miR-124-3p functions as a tumor suppressor in breast cancer by targeting CBL.

    abstract：BACKGROUND:The origin and development of breast cancer remain complex and obscure. Recently, microRNA (miRNA) has been identified as an important regulator of the initiation and progression of breast cancer, and some studies have shown the essential role of miR-124-3p as a tumor suppressor in breast tumorigenesis. Howe...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-016-2862-4

    authors： Wang Y,Chen L,Wu Z,Wang M,Jin F,Wang N,Hu X,Liu Z,Zhang CY,Zen K,Chen J,Liang H,Zhang Y,Chen X

    更新日期：2016-11-15 00:00:00

  • Development of mobile technologies for the prevention of cervical cancer in Santiago, Chile study protocol: a randomized controlled trial.

    abstract：BACKGROUND:In Chile, more than 500 women die every year from cervical cancer, and a majority of Chilean women are not up-to-date with their Papanicolau (Pap) test. Mobile health has great potential in many health areas, particularly in health promotion and prevention. There are no randomized controlled trials in Latin ...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-017-3870-8

    authors： Momany MC,Martinez-Gutierrez J,Soto M,Capurro D,Ciampi F,Thompson B,Puschel K

    更新日期：2017-12-13 00:00:00

  • Decentral gene expression analysis: analytical validation of the Endopredict genomic multianalyte breast cancer prognosis test.

    abstract：BACKGROUND:EndoPredict (EP) is a clinically validated multianalyte gene expression test to predict distant metastasis in ER-positive, HER2-negative breast cancer treated with endocrine therapy alone. The test is based on the combined analysis of 12 genes in formalin-fixed, paraffin-embedded (FFPE) tissue by reverse tra...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/1471-2407-12-456

    authors： Kronenwett R,Bohmann K,Prinzler J,Sinn BV,Haufe F,Roth C,Averdick M,Ropers T,Windbergs C,Brase JC,Weber KE,Fisch K,Müller BM,Schmidt M,Filipits M,Dubsky P,Petry C,Dietel M,Denkert C

    更新日期：2012-10-05 00:00:00

  • The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patients.

    abstract：BACKGROUND:In metastatic breast cancer (MBC), antigen profiles of metastatic tissue and primary tumor differ in up to 20 % of patients. Reassessment of predictive markers, including human epidermal growth factor receptor 2 (HER2) expression, might help to optimize MBC treatment. While tissue sampling is invasive and of...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-015-1423-6

    authors： Wallwiener M,Hartkopf AD,Riethdorf S,Nees J,Sprick MR,Schönfisch B,Taran FA,Heil J,Sohn C,Pantel K,Trumpp A,Schneeweiss A

    更新日期：2015-05-14 00:00:00

  • Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial).

    abstract：BACKGROUND:Triple-negative breast cancer (TNBC) comprises a heterogeneous group of diseases which are generally associated with poor prognosis. Up to now, no targeted treatment beyond anti-VEGF therapy has been approved for TNBC and cytotoxic agents remain the mainstay of treatment. Ixazomib is a selective and reversib...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-018-4979-0

    authors： Rinnerthaler G,Gampenrieder SP,Petzer A,Burgstaller S,Fuchs D,Rossmann D,Balic M,Egle D,Rumpold H,Singer CF,Bartsch R,Petru E,Melchardt T,Ulmer H,Mlineritsch B,Greil R

    更新日期：2018-11-06 00:00:00

  • Efficacy and safety of self-expanding metallic stent placement followed by neoadjuvant chemotherapy and scheduled surgery for treatment of obstructing left-sided colonic cancer.

    abstract：BACKGROUND:This study aimed to evaluate the safety and feasibility of self-expanding metallic stent (SEMS) followed by neoadjuvant chemotherapy prior to elective surgery for obstructing left-sided colon cancer. METHODS:Eleven consecutive patients with obstructing left-sided colon cancer between May 2014 and November 2...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-020-6560-x

    authors： Han JG,Wang ZJ,Zeng WG,Wang YB,Wei GH,Zhai ZW,Zhao BC,Yi BQ

    更新日期：2020-01-28 00:00:00

  • Cancers of unknown primary origin (CUP) are characterized by chromosomal instability (CIN) compared to metastasis of know origin.

    abstract：BACKGROUND:Cancers of unknown primary (CUPs) constitute ~5% of all cancers. The tumors have an aggressive biological and clinical behavior. The aim of the present study has been to uncover whether CUPs exhibit distinct molecular features compared to metastases of known origin. METHODS:Employing genome wide transcripto...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-015-1128-x

    authors： Vikeså J,Møller AK,Kaczkowski B,Borup R,Winther O,Henao R,Krogh A,Perell K,Jensen F,Daugaard G,Nielsen FC

    更新日期：2015-03-19 00:00:00

  • Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016.

    abstract：BACKGROUND:Cancer patient pathways (CPPs) were implemented in 2015 to reduce waiting time, regional variation in waiting time, and to increase the predictability of cancer care for the patients. The aims of this study were to see if the national target of 70% of all cancer patients being included in a CPP was met, and ...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-020-06979-y

    authors： Nilssen Y,Brustugun OT,Eriksen MT,Haug ES,Naume B,Møller B

    更新日期：2020-05-30 00:00:00

  • A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG).

    abstract：BACKGROUND:Bevacizumab, an antibody neutralizing Vascular Endothelial Growth Factor (VEGF), is licensed for the management of patients with advanced colon cancer. However, tumor biomarkers identifying the molecular tumor subsets most amenable to angiogenesis modulation are lacking. METHODS:We profiled expession of 245...

    journal_title：BMC cancer

    pub_type： 杂志文章,多中心研究

    doi：10.1186/1471-2407-14-111

    authors： Pentheroudakis G,Kotoula V,Fountzilas E,Kouvatseas G,Basdanis G,Xanthakis I,Makatsoris T,Charalambous E,Papamichael D,Samantas E,Papakostas P,Bafaloukos D,Razis E,Christodoulou C,Varthalitis I,Pavlidis N,Fountzilas G

    更新日期：2014-02-20 00:00:00

  • Platelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapy.

    abstract：BACKGROUND:Platelet to Lymphocyte ratio (PLR) is thought to be associated with a worse outcome in multiple types of cancer. However, the prognostic significance of PLR has not been investigated in the prostate cancer (PCa) patients receiving hormonal therapy. The objective of this study was to determine the prognostic ...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-016-2363-5

    authors： Wang Y,Xu F,Pan J,Zhu Y,Shao X,Sha J,Wang Z,Cai Y,Liu Q,Dong B,Xue W,Huang Y

    更新日期：2016-05-24 00:00:00